Jazz Pharmaceuticals advertising spend, FY2025
Jazz Pharmaceuticals (JAZZ) reported $106M of advertising expense for the fiscal year ended Dec 31, 2025. That is 2.5% of revenue of $4.3B. Down 1.7% from FY2024.
Key facts
- Ad spend is 3.8x its FY2015 level ($27.9M), faster than revenue (3.2x).
- The highest year on file is FY2021 at $162M; FY2025 is 35% below it.
- Largest increase +2470.0% in FY2014; largest cut -37.5% in FY2011.
- Ad spend is 2.5% of revenue, down from 4.2% in FY2020.
- Jazz Pharmaceuticals spends more on advertising than 28% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is below the median of 4.5%.
Ad spend by fiscal year
Ad spend as % of revenue
Ad spend in context, FY2025
Advertising was 5.8% of selling, general and administrative expense. Research and development spending was 7.4x advertising. The company reported an operating loss of $430M.
| Advertising | $106M | AdvertisingExpense |
|---|---|---|
| Selling, general and administrative | $1.8B | ad spend = 5.8% |
| Research and development | $783M | R&D = 7.4x ad spend |
| Operating loss | -$430M | |
| Net loss | -$356M |
Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106M | -1.7% | $4.3B | 2.5% | AdvertisingExpense | 10-K Feb 24, 2026 |
| FY2024 | Dec 31, 2024 | $107M | +16.5% | $4.1B | 2.6% | AdvertisingExpense | 10-K Feb 24, 2026 |
| FY2023 | Dec 31, 2023 | $92.2M | -15.3% | $3.8B | 2.4% | AdvertisingExpense | 10-K Feb 24, 2026 |
| FY2022 | Dec 31, 2022 | $109M | -32.6% | $3.7B | 3.0% | AdvertisingExpense | 10-K Feb 26, 2025 |
| FY2021 | Dec 31, 2021 | $162M | +62.1% | $3.1B | 5.2% | AdvertisingExpense | 10-K Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $99.6M | +52.3% | $2.4B | 4.2% | AdvertisingExpense | 10-K Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $65.4M | +74.9% | $2.2B | 3.0% | AdvertisingExpense | 10-K Mar 1, 2022 |
| FY2018 | Dec 31, 2018 | $37.4M | +2.2% | $1.9B | 2.0% | AdvertisingExpense | 10-K Feb 23, 2021 |
| FY2017 | Dec 31, 2017 | $36.6M | +24.1% | $1.6B | 2.3% | AdvertisingExpense | 10-K Feb 25, 2020 |
| FY2016 | Dec 31, 2016 | $29.5M | +5.7% | $1.5B | 2.0% | AdvertisingExpense | 10-K Feb 26, 2019 |
| FY2015 | Dec 31, 2015 | $27.9M | +8.6% | $1.3B | 2.1% | AdvertisingExpense | 10-K Feb 27, 2018 |
| FY2014 | Dec 31, 2014 | $25.7M | +2470.0% | $1.2B | 2.2% | AdvertisingExpense | 10-K Feb 28, 2017 |
| FY2013 | Dec 31, 2013 | $1M | +42.9% | $872M | 0.1% | AdvertisingExpense | 10-K Feb 23, 2016 |
| FY2012 | Dec 31, 2012 | $700K | -30.0% | $586M | 0.1% | AdvertisingExpense | 10-K Feb 24, 2015 |
| FY2011 | Dec 31, 2011 | $1M | -37.5% | $272M | 0.4% | AdvertisingExpense | 10-K Feb 25, 2014 |
| FY2010 | Dec 31, 2010 | $1.6M | +300.0% | $174M | 0.9% | AdvertisingExpense | 10-K Feb 26, 2013 |
| FY2009 | Dec 31, 2009 | $400K | n/a | $128M | 0.3% | AdvertisingExpense | 10-K Feb 28, 2012 |
Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to Jazz Pharmaceuticals in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 326 | T. Rowe Price | $107M | 1.5% | -17.1% | FY2025 |
| 327 | Coursera | $107M | 14.1% | +70.7% | FY2025 |
| 328 | RH | $106M | 3.1% | -13.1% | FY2026 |
| 329 | Brilliant Earth Group | $106M | 24.2% | -2.2% | FY2025 |
| 330 | Jazz Pharmaceuticals | $106M | 2.5% | -1.7% | FY2025 |
| 331 | BGC Group | $105M | 3.6% | +49.3% | FY2025 |
| 332 | Oxford Industries | $104M | 7.0% | -6.3% | FY2026 |
Full ranking of 458 companies · Biggest cuts #116 · Ads above operating profit #117
Questions
How much does Jazz Pharmaceuticals spend on advertising?
Jazz Pharmaceuticals spent $106M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 24, 2026.
What percentage of revenue does Jazz Pharmaceuticals spend on advertising?
2.5% of revenue in fiscal 2025 ($106M against $4.3B). The median across the 458 companies tracked is 4.5%.
Is Jazz Pharmaceuticals spending more on advertising?
No. Ad spend fell 1.7% in fiscal 2025 from fiscal 2024.
How does Jazz Pharmaceuticals rank by advertising spend?
#330 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
Does Jazz Pharmaceuticals spend more on advertising than on R&D?
No. In fiscal 2025 it spent $783M on research and development and $106M on advertising.
What does Jazz Pharmaceuticals's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Company and source
- Filing
- 10-K for FY2025, filed Feb 24, 2026
- Accession number
0001232524-26-000013- Company
- Jazz Pharmaceuticals plc, CIK 1232524, SIC 2834 (Pharmaceutical Preparations)
- Headquarters
- Dublin
- Incorporated in
- L2
- Fiscal year ends
- December 31
- Listed on
- Nasdaq
- SEC filer status
- Large accelerated filer
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
- Cite
- Jazz Pharmaceuticals advertising spend, FY2009-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 24, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/jazz-pharmaceuticals/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies